Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Author index

Page Path
HOME > Browse > Author index
Search
Won-Suk An  (An WS) 1 Article
Urinary Neutrophil Gelatinase-Associated Lipocalin Levels in Comparison with Glomerular Filtration Rate for Evaluation of Renal Function in Patients with Diabetic Chronic Kidney Disease
Kwang-Sook Woo, Jae-Lim Choi, Bo-Ram Kim, Ji-Eun Kim, Won-Suk An, Jin-Yeong Han
Diabetes Metab J. 2012;36(4):307-313.   Published online August 20, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.4.307
  • 4,397 View
  • 27 Download
  • 25 Crossref
AbstractAbstract PDFPubReader   
Background

Neutrophil gelatinase-associated lipocalin (NGAL) is a promising biomarker of acute kidney injury. There is a growing body of evidence suggesting that NGAL is also a marker of kidney disease and severity in chronic kidney disease (CKD). We studied the utility of urinary NGAL in more accurately predicting renal function in patients with diabetic CKD.

Methods

We studied possible relationships between urinary NGAL, estimated glomerular filtration rate (eGFR), and proteinuria in diabetic CKD patients and in healthy populations.

Results

Urinary NGAL levels were significantly higher in CKD patients than in healthy controls (96.0 [2.7 to 975.2] ng/mL vs. 18.8 [1.3 to 81.9] ng/mL, P=0.02), and the GFR was lower among CKD patients (49.3 [13.1 to 78.3] mL/min/1.73 m2 vs. 85.6 [72 to 106.7] mL/min/1.73 m2, P<0.0001). The urinary NGAL level showed a significant inverse correlation with GFR (r=-0.5634, P<0.0001). The correlation analyses between urinary protein level and urinary NGAL levels and GFR were as follows: urine protein and urinary NGAL (r=0.3009, P=0.0256), urine protein and GFR (r=-0.6245, P<0.0001), urine microalbumin and urinary NGAL (r=0.1794, P=0.2275), and urine microalbumin and GFR (r=-0.5190, P=0.0002).

Conclusion

From these results, we concluded that urinary NGAL is a reliable marker of renal function in diabetic CKD patients. However, urinary NGAL did not provide more accurate information regarding renal function than GFR.

Citations

Citations to this article as recorded by  
  • Nanoparticle-antibody conjugate-based immunoassays for detection of CKD-associated biomarkers
    Monika Chhillar, Deepak kukkar, Preeti Kukkar, Ki-Hyun Kim
    TrAC Trends in Analytical Chemistry.2023; 158: 116857.     CrossRef
  • Fecal and Urinary Adipokines as Disease Biomarkers
    Hauke C. Tews, Tanja Elger, Thomas Grewal, Simon Weidlich, Francesco Vitali, Christa Buechler
    Biomedicines.2023; 11(4): 1186.     CrossRef
  • Application of SERS-based nanobiosensors to metabolite biomarkers of CKD
    Deepak Kukkar, Monika Chhillar, Ki-Hyun Kim
    Biosensors and Bioelectronics.2023; 232: 115311.     CrossRef
  • A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy
    Marwa Mohsen, Ahmed A. Elberry, Alaa Mohamed Rabea, Doaa Mahmoud Khalil, Mohamed E.A. Abdelrahim, Raghda R.S. Hussein
    Canadian Journal of Diabetes.2022; 46(2): 134.     CrossRef
  • Serum Neutrophil Gelatinase Associated Lipocalin in Patients with Toxic Nephropathies. Prospective Study
    Lyudmila A. Demidchik, Valentina V. Lee, Dmitriy A. Klyuyev, Ryszhan Y. Bakirova, Vilen B. Molotov-Luchanskiy, Yelena V. Pozdnyakova, Irina V. Beinikova, Semyon S. Bobyrev
    Annals of the Russian academy of medical sciences.2021; 76(2): 142.     CrossRef
  • Assessment of Renal Function Status in Steady-State Sickle Cell Anaemic Children Using Urine Human Neutrophil Gelatinase-Associated Lipocalin and Albumin:Creatinine Ratio
    Olatubosun Oladipupo Olawale, Abiodun Folasade Adekanmbi, Ayobola Abimbola Sonuga, Oyebola Oluwagbemiga Sonuga, Samuel Olufemi Akodu, Morufat Mojisola Ogundeyi
    Medical Principles and Practice.2021; 30(6): 557.     CrossRef
  • Association of neutrophil-gelatinase-associated lipocalin with microvascular complications in patients with type 2 diabetes: a cross-sectional study
    Erhan Aslanhan, David Ojalvo, Ekmek Burak Özsenel, Sema Ucak Basat, Fatih Borlu
    Cardiovascular Endocrinology & Metabolism.2019; 8(3): 82.     CrossRef
  • MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update
    Qinghua Cao, Xin‐Ming Chen, Chunling Huang, Carol A. Pollock
    FASEB BioAdvances.2019; 1(6): 375.     CrossRef
  • Potential serum biomarkers for early detection of diabetic nephropathy
    Tarek Kamal Motawi, Nagwa Ibrahim Shehata, Mahmoud Mohamed ElNokeety, Yasmin Farid El-Emady
    Diabetes Research and Clinical Practice.2018; 136: 150.     CrossRef
  • Modern methods of diagnosing chronic kidney disease in patients with diabetes mellitus
    Tatiana N. Markova, Viktoriia V. Sadovskaya, Marina Y. Bespyatova
    Diabetes mellitus.2018; 20(6): 454.     CrossRef
  • Evaluation value of neutrophil gelatinase‐associated lipocalin for the renal dysfunction of patients with chronic kidney disease: A meta‐analysis
    Lulu Guo, Yaya Zhao, Zhenzhu Yong, Weihong Zhao
    AGING MEDICINE.2018; 1(2): 185.     CrossRef
  • Urinary Tubular Injury Biomarkers Are Associated With ESRD and Death in the REGARDS Study
    Ruth F. Dubin, Suzanne Judd, Rebecca Scherzer, Michael Shlipak, David G. Warnock, Mary Cushman, Mark Sarnak, Chirag Parikh, Michael Bennett, Neil Powe, Carmen A. Peralta
    Kidney International Reports.2018; 3(5): 1183.     CrossRef
  • Add-on plasmonic patch as a universal fluorescence enhancer
    Jingyi Luan, Jeremiah J. Morrissey, Zheyu Wang, Hamed Gholami Derami, Keng-Ku Liu, Sisi Cao, Qisheng Jiang, Congzhou Wang, Evan D. Kharasch, Rajesh R. Naik, Srikanth Singamaneni
    Light: Science & Applications.2018;[Epub]     CrossRef
  • Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
    Marcelo R. Bacci, Ethel Z. Chehter, Ligia A. Azzalis, Beatriz Costa de Aguiar Alves, Fernando L.A. Fonseca
    Kidney International Reports.2017; 2(2): 152.     CrossRef
  • Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
    Bancha Satirapoj, Chagriya Kitiyakara, Asada Leelahavanichkul, Yingyos Avihingsanon, Ouppatham Supasyndh
    BMC Nephrology.2017;[Epub]     CrossRef
  • Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy
    Mohamed H. Mahfouz, Adel M. Assiri, Mohammed H. Mukhtar
    Biomarker Insights.2016; 11: BMI.S33191.     CrossRef
  • Intra-abdominal Hypertension and Postoperative Kidney Dysfunction in Cardiac Surgery Patients
    Michael A. Mazzeffi, Patrick Stafford, Karin Wallace, Wendy Bernstein, Seema Deshpande, Patrick Odonkor, Ashanpreet Grewal, Erik Strauss, Latoya Stubbs, James Gammie, Peter Rock
    Journal of Cardiothoracic and Vascular Anesthesia.2016; 30(6): 1571.     CrossRef
  • Effects of Therapy on Urine Neutrophil Gelatinase-Associated Lipocalin in Nondiabetic Glomerular Diseases with Proteinuria
    Amnuay Sirisopha, Somlak Vanavanan, Anchalee Chittamma, Bunyong Phakdeekitcharoen, Ammarin Thakkinstian, Amornpan Lertrit, Nuankanya Sathirapongsasuti, Chagriya Kitiyakara
    International Journal of Nephrology.2016; 2016: 1.     CrossRef
  • Novel urinary biomarkers in pre-diabetic nephropathy
    Vikas Garg, Manish Kumar, Himansu Sekhar Mahapatra, Anubhuti Chitkara, Adesh Kumar Gadpayle, Venketansan Sekhar
    Clinical and Experimental Nephrology.2015; 19(5): 895.     CrossRef
  • High expression of neutrophil gelatinase-associated lipocalin (NGAL) in the kidney proximal tubules of diabetic rats
    Fenghua Liu, Huayu Yang, Haiping Chen, Mi Zhang, Qing Ma
    Advances in Medical Sciences.2015; 60(1): 133.     CrossRef
  • Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial
    Sawako Kato, Shoichi Maruyama, Hirofumi Makino, Jun Wada, Daisuke Ogawa, Takashi Uzu, Hisazumi Araki, Daisuke Koya, Keizo Kanasaki, Yutaka Oiso, Motomitsu Goto, Akira Nishiyama, Hiroyuki Kobori, Enyu Imai, Masahiko Ando, Seiichi Matsuo
    Clinical and Experimental Nephrology.2015; 19(6): 1098.     CrossRef
  • The inflammation–lipocalin 2 axis may contribute to the development of chronic kidney disease
    Atsushi Hashikata, Akiko Yamashita, Shigeki Suzuki, Shintaro Nagayasu, Takanori Shinjo, Ataru Taniguchi, Mitsuo Fukushima, Yoshikatsu Nakai, Kazuko Nin, Naoya Watanabe, Tomoichiro Asano, Yoshimitsu Abiko, Akifumi Kushiyama, Shoichiro Nagasaka, Fusanori Ni
    Nephrology Dialysis Transplantation.2014; 29(3): 611.     CrossRef
  • Urinary Neutrophil Gelatinase Associated Lipocalin as a Marker of Tubular Damage in Type 2 Diabetic Patients with and without Albuminuria
    Abeer A. Al-Refai, Safaa I. Tayel, Ahmed Ragheb, Ashraf G. Dala, Ahmed Zahran
    Open Journal of Nephrology.2014; 04(01): 37.     CrossRef
  • Importance of Neutrophil Gelatinase-Associated Lipocalin in Differential Diagnosis of Acute and Chronic Renal Failure
    Seda Ozkan, Polat Durukan, Cemil Kavalci, Ali Duman, Mustafa Burak Sayhan, Omer Salt, Afsin Ipekci
    Iranian Red Crescent Medical Journal.2014;[Epub]     CrossRef
  • Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia
    Jing Xiao, Jianying Niu, Xianwu Ye, Qianqian Yu, Yong Gu
    Hypertension in Pregnancy.2013; 32(4): 439.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer